References
- ANIS , H.A. , HOGG , R.S. , WANG , X. , YIP , B. , PALEPU , A. , MONTANER , J.S.G. , O'SHAUGHNESSY , M.V. and SCHECHTHR , M.T. 1998 . Modelling the potential economic impact of viral load-driven triple drug combination antiretroviral therapy . PharmacoEconomics , 13 (6) : 697 – 705 .
- BECK , E.J. , TOLLEY , K. , POWER , A. , MANDALIA , S. , RUTTER , P. , IZUMI , J. , BEECHAM , J. , GRAY , A. , BARLOW , D. , EASTERBROOK , P. , FISHER , M. , INNES , J. , KINGHORN , G. , MANDEL , B. , POZNIAK , A. , TANG , A. , TOMLINSON , D. and WILLIAMS , I. 1998 . The use and cost of HIV service provision in England in 1996 . PharmacoEconomics , 14 (6) : 639 – 652 .
- BRETTLE , R.P. , ATKINSON , F.I. , WILCOCK , J. , RICHARDSON , A. , LEWIS , R. , MACCALLUM , L. and BATH , G. 1997 . The cost of health care for HIV-positive patients . International of Journal STD & AIDS , 8 (1) : 50 – 53 .
- BRUNO , R. , SACCHI , P. , PUTRUNO , S.F.A. , DI LUZIO PAPARATHI , U. , FONT , M. , PIACENTINI , P. , ZARA , F. , LEGNAZZI , P. and FILICE , G. 1999 . HAART (Zidovudina, Lamivudina, Indinavir): analisi dei costi in una popolazione di pazienti HIV positivi con conta linfocitaria CD4 + < 200/mmc . PharmacoEconomics , 1 (1) : 35 – 41 .
- CENTERS FOR DISEASE CONTROL AND PREVENTION . 1992 . Classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults . MMWR-Morbidity & Mortality Weekly Report , 41 (RR-17) : 1 – 19 .
- DEGRAEVE , D. , LESCRAUWAET , B. and NONNEMAN , W. 1997 . Patient classification and cost analysis of AIDS and HIV: the case of Belgium . Health Policy , 39 : 93 – 106 .
- GARATTINI , L. 1992 . Italian health care reform , York : University (CHE Occasional Papers) .
- GARATTINI , L. , GIULIANI , G. and PAGANO , E. 1999 . A model for calculating costs of hospital wards: an Italian experience . Journal of Management in Medicine , 13 (2) : 71 – 82 .
- GEBO , K.A. , CHAISSON , R.E. , FOLKEMER , J.G. , BARTLETT , J.G. and MOORE , R.D. 1999 . Costs of HIV medical care in the era of highly active antiretroviral therapy . AIDS , 13 (8) : 963 – 969 .
- HAMMER , S.M. , SQUIRES , K.E. , HUGHES , M.D. , GRIMEAS , J.M. , DEMETER , L.M. , CURRIER , J.S. , ERON , JJ. JR , FEINBERG , J.E. , BALFOUR , H.H. JR , DEYTON , L.R. , CHODAKEWITZ , J.A. and FISCHL , M.A. 1997 . A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team . New England Journal of Medicine , 337 (11) : 725 – 733 .
- HOGG , R.S. , HEATH , K.V. , YIPM , B. , CRAIB , K.J. , O'SHAUGHNESSY , M.V. , SCHECHTER , M.T. and MONTANER , J.S. 1998 . Improved survival among HIV-infected individuals following initiation of atiretroviral therapy . Journal of the American Medical Association , 279 (6) : 450 – 54 .
- HURLEY , S.F. , KALDOR , J.M. , GARDINER , S. , CARLIN , J.B. , ASSUNCÀO , M.R. and EVANS , D.B. 1996 . Lifetime cost of human immunodeficiency virus-related health care . Journal of Acquired lmmune Deficiency Syndrome and Human Retrovirology , 12 : 371 – 378 .
- MARKOWITZ , M. , SAAG , M. , POWDERLY , W.G. , HURLEY , A.M. , HSU , A. , VALDES , J.M. , HENRY , D. , SATTLER , F. , LA MARCA , A. LEONARD , J.M. 1995 . A Preliminary Study of Ritonavir, an Inhibitor of HIV-1 Protease, to Treat HIV-I Infection . New England Journal Medicine , 333 (23) : 1534 – 1539 .
- MOCROFT , A. , VELLA , S. , BENFIELD , T.L , CHIESI , A. , MILLER , V. , GARGALIANOS , P. , D'ARMINIO MONFORTE , A. , YUST , L , BRUUN , J.N. , PHILIPS , A.N. and LUNDGREN , J.D. 1998 . Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group . The Lancet , 352 (9142) : 1725 – 1730 .
- MOLE , L. , OCKRIM , K. and HOLODNIY , M. 1999 . Decreased medical expenditure for care of HIV-seropositive patients. the impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center . PharmacoEconomics , 16 (3) : 307 – 315 .
- ORZELIA , L. , TEDIOSI , F. and GARATTINI , L. 1999 . La valutazione dei costi ospedalieri in un reparto di malattie infettive: il caso degli Ospedali Riuniti di Bergamo . ASI , 40 : 22 – 28 .
- PALELLA , FJ JR. , DELANEY , K.M. , MOORMAN , A.C. , LOVELESS , M.O. , FUHRER , J. , SATTEN , G.A. , ASCHMAN , DJ. and HOLMBERG , S.D. 1998 . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators . New England Journal of Medicine , 338 (13) : 853 – 860 .
- POSTMA , M.A. , JAGER , J.C. , DIJKGRAAF , J.W. , BORLEFF , J.C.C. , TOLLEY , K. and LEIDL , R.M. 1995 . AIDS scenario for the Netherlands; the economic impact on hospitals . Health Policy , 31 : 127 – 150 .
- RABENECK , L. , MENKE , T. and WRAY , N.P. 1999 . How Good are US Studies of HIV Costs of Care? . Medical Care , 37 (8) : 748 – 759 .
- TORRES , R.A. and BARR , M. 1997 . Impact of combination therapy for HIV infection on inpatient census . New England Journal of Medicine , 336 (21) : 1531 – 1532 .
- TRAMARIN , A. , CAMPOSTRNI , S. , TOLLEY , K. and DE LALLA , F. 1997 . The influence of socioeconomic status on health service utilisation by patients with AIDS in North Italy. The North-East Italian Group for Planning of AIDS Health Care . Social Science and Medicine , 45 (6) : 859 – 866 .
- YIN , D. , TEDIOSI , F. , Di CINTIO , E. , PARAZZINI , F. and GARATTINI , L. 2000 . Patients on highly active antiretroviral therapy (HAART) are more likely to remain employed in Italy , Stockholm : 10th European Congress on Clinical Microbiology and Infectious Diseases . (abstract 28-31)